The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exposure-response analyses from a randomized dose optimization study of telisotuzumab adizutecan (Temab-A) in combination with bevacizumab in patients with metastatic colorectal cancer (mCRC).
 
Mohammad Alshaer
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Research Funding - Abbvie
 
Heiko Babel
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Research Funding - Abbvie
 
Benjamin Engelhardt
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Research Funding - Abbvie
 
Michael Burns
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Research Funding - Abbvie
 
Yinuo Pang
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Research Funding - Abbvie
 
Apurvasena Parikh
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie